|
Re: The runway is clear....
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 12:02PM
|
|
Re: The runway is clear....
|
1
|
Resverlogix Corp.
|
Dec 07, 2018 11:40AM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 11:35AM
|
|
Re: ACC 2019?
|
4
|
Resverlogix Corp.
|
Dec 07, 2018 10:35AM
|
|
Re: ACC 2019?
|
4
|
Resverlogix Corp.
|
Dec 06, 2018 05:23PM
|
|
Re: The runway is clear....
|
4
|
Resverlogix Corp.
|
Dec 06, 2018 11:20AM
|
|
Re: Bio Europe slide deck
|
4
|
Zenith Epigenetics
|
Dec 06, 2018 09:26AM
|
|
Re: 2019 Potential Events
|
3
|
Resverlogix Corp.
|
Dec 05, 2018 11:22PM
|
|
The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 05, 2018 04:13PM
|
|
Re: An email and response from another poster.
|
4
|
Resverlogix Corp.
|
Dec 04, 2018 09:34PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 08:44PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 08:04PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 04:25PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 01:35PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 01:20PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 11:00AM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 09:44AM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
5
|
Resverlogix Corp.
|
Dec 03, 2018 10:25PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 04:03PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
5
|
Resverlogix Corp.
|
Dec 03, 2018 03:42PM
|
